GVHD Prophylaxis in Line with Standards in Eastern Mediterranean Centers

Most patients who undergo allogenic hematopoietic stem cell transplant (allo-HSCT) at centers in the East Mediterranean (EM) region will receive graft-vs-host disease (GVHD) prophylaxis with standard-of-care agents, with prophylaxis practices in…